gfcdiagnostics.com
nature publishing group Bronchodilatory Effect of the PPAR-γ Agonist Rosiglitazone in Smokers With Asthma M Spears1, I Donnelly2, L Jolly2, M Brannigan1, K Ito3, C McSharry2, J Lafferty1, R Chaudhuri1, G Braganza1, P Bareille4, L Sweeney4, IM Adcock3, PJ Barnes3, S Wood5 and NC Thomson1 Smokers with asthma show a reduced response to inhaled subtypes in vitro and reduce inflammation